Companies: 10,795·Total market cap: $144.5T
Tenet Healthcare Corporation

Tenet Healthcare Corporation

THCNYSEHealthcare● Active
$162.12
+$0.06(+0.04%)
Market Cap$14.0B
P/E Ratio
52W High$247.21
52W Low$146.6
Overview

Tenet Healthcare Corporation (THC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

thc · stock forecast · 32 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 32 Wall Street analysts in the past 3 months

SellBuy

Buy

32 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
26
Hold
6
Sell
0
Strong Sell
0
Total: 32 · Buy rate: 81.3%

12-Month Price Target

High

$288

Consensus

$260

+60.8% upside

Low

$210

Median: $262.5 · Last Close: $161.43

The Tenet Healthcare Corporation (THC) analyst consensus is Buy, based on ratings from 32 Wall Street analysts over the past 3 months. The average 12-month THC price target is $259.50, representing +60.8% upside from the current price of $161.43.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $260 (60.8%)

Consensus Target

$259.50

60.8% upside

High Target

$288

78.4%

Low Target

$210

30.1%

Current Price

$161.43

as of today

Based on analyst price targets, the THC stock price prediction for the next 12 months ranges from $210 to $288. The consensus THC price forecast of $259.50 implies 60.8% upside from the current price of $161.43.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$153.365.00%

1-day model range: $152.49–$154.23. Peak: $154.23 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$224+38.5%
2028$280+73.2%
2029$325+101.5%
2030$360+122.8%
2031+138.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%
1Buy
0Neutral
13Sell
RSI (14)21.1Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · THC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$162.66SELL
MA 10$168.93SELL
MA 20$179.55SELL
MA 50$185.66SELL
MA 100$199.46SELL
MA 200$199.08SELL
Current $THC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$163.81SELL
EMA 10$168.43SELL
EMA 20$175.08SELL
EMA 50$185.66SELL
EMA 100$192.50SELL
EMA 200$190.65SELL
Current $THC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barclays2026-05-05
Maintains
OverweightOverweight
Baird2026-05-05
Maintains
NeutralNeutral
Stephens & Co.2026-05-04
Maintains
OverweightOverweight
Guggenheim2026-05-01
Maintains
BuyBuy
Wells Fargo2026-05-01
Maintains
OverweightOverweight
Keybanc2026-05-01
Maintains
OverweightOverweight
RBC Capital2026-05-01
Maintains
OutperformOutperform
Guggenheim2026-03-12
Maintains
BuyBuy
Mizuho2026-03-12
Maintains
OutperformOutperform
Leerink Partners2026-02-20
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Tenet Healthcare Corporation (THC) stock. Of the recent 324 rating actions, 33 were upgrades and 22 were downgrades. 32 analysts currently cover THC.

Analyst Recommendation Trends

Buy ratings46↑ +2
Hold ratings01↑ +1
Sell ratings00

THC analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 6 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$21.3B

↓ 4.8% YoY

Revenue Next Year

$22.0B

↑ 3.3% YoY

EPS This Year

$16.09

EPS Next Year

$17.88

↑ 11.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast THC EPS of $16.09 for the current fiscal year, based on estimates from 15 analysts. The THC revenue forecast is $21.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The THC stock forecast is supported by two independent data sources: analyst consensus ratings from 32 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus THC price target is $259.50 (+60.8% upside), with an analyst consensus of Buy.

The THC short-term stock prediction for tomorrow is $153.36 (-5.00%). The THC stock price prediction for 2027 estimates an average of $224. The THC stock prediction for 2030 projects a range of $343–$377.

Tenet Healthcare Corporation trades on NYSE under the ticker THC. The THC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 81% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

THC forecast · 8 questions

According to 32 Wall Street analysts, the average 12-month THC price target is $259.50, with a high forecast of $288.00 and a low of $210.00. The median price target is shown in the chart above when available. This implies +60.8% potential upside from the current price of $161.43.

THC price targetWhat is THC price targetTHC analyst price targetTHC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.